213 related articles for article (PubMed ID: 36175833)
1. The Role of Metabolism in Migraine Pathophysiology and Susceptibility.
Grech O; Mollan SP; Wakerley BR; Fulton D; Lavery GG; Sinclair AJ
Life (Basel); 2021 May; 11(5):. PubMed ID: 34062792
[TBL] [Abstract][Full Text] [Related]
2. Influence of metabolic state and body composition on the action of pharmacological treatment of migraine.
Bruijn N; van Lohuizen R; Boron M; Fitzek M; Gabriele F; Giuliani G; Melgarejo L; Řehulka P; Sebastianelli G; Triller P; Vigneri S; Özcan B; van den Brink AM;
J Headache Pain; 2024 Feb; 25(1):20. PubMed ID: 38347465
[TBL] [Abstract][Full Text] [Related]
3. Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers.
Gross EC; Putananickal N; Orsini AL; Schoenen J; Fischer D; Soto-Mota A
Sci Rep; 2023 Mar; 13(1):3787. PubMed ID: 36882474
[TBL] [Abstract][Full Text] [Related]
4. Chronic Migraine: Diagnosis and Management.
Kung D; Rodriguez G; Evans R
Neurol Clin; 2023 Feb; 41(1):141-159. PubMed ID: 36400552
[TBL] [Abstract][Full Text] [Related]
5. Management of chronic migraine.
Hovaguimian A; Roth J
BMJ; 2022 Oct; 379():e067670. PubMed ID: 36216384
[TBL] [Abstract][Full Text] [Related]
6. Future targets for migraine treatment beyond CGRP.
Al-Hassany L; Boucherie DM; Creeney H; van Drie RWA; Farham F; Favaretto S; Gollion C; Grangeon L; Lyons H; Marschollek K; Onan D; Pensato U; Stanyer E; Waliszewska-Prosół M; Wiels W; Chen HZ; Amin FM;
J Headache Pain; 2023 Jun; 24(1):76. PubMed ID: 37370051
[TBL] [Abstract][Full Text] [Related]
7. Energy metabolism disturbance in migraine: From a mitochondrial point of view.
Wang Y; Wang Y; Yue G; Zhao Y
Front Physiol; 2023; 14():1133528. PubMed ID: 37123270
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials.
Haghdoost F; Puledda F; Garcia-Azorin D; Huessler EM; Messina R; Pozo-Rosich P
Cephalalgia; 2023 Apr; 43(4):3331024231159366. PubMed ID: 36855951
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis.
Messina R; Huessler EM; Puledda F; Haghdoost F; Lebedeva ER; Diener HC
Cephalalgia; 2023 Mar; 43(3):3331024231152169. PubMed ID: 36786548
[TBL] [Abstract][Full Text] [Related]
10. Proteomic and metabolomic profiling of acupuncture for migraine reveals a correlative link via energy metabolism.
Liu L; Li W; Wang L; Gong P; Lyu T; Liu D; Zhang Y; Guo Y; Liu X; Tang M; Hu H; Liu C; Li B
Front Neurosci; 2022; 16():1013328. PubMed ID: 36248663
[TBL] [Abstract][Full Text] [Related]
11. Immunologic aspects of migraine: A review of literature.
Salahi M; Parsa S; Nourmohammadi D; Razmkhah Z; Salimi O; Rahmani M; Zivary S; Askarzadeh M; Tapak MA; Vaezi A; Sadeghsalehi H; Yaghoobpoor S; Mottahedi M; Garousi S; Deravi N
Front Neurol; 2022; 13():944791. PubMed ID: 36247795
[TBL] [Abstract][Full Text] [Related]
12. The Pressure of Headache at the United Kingdom CSF Disorders Day 2023.
Berman G; Mollan SP
Neuroophthalmology; 2024; 48(3):204-209. PubMed ID: 38756340
[TBL] [Abstract][Full Text] [Related]
13. The Role of Astrocytes in Migraine with Cortical Spreading Depression: Protagonists or Bystanders? A Narrative Review.
Yang MF; Ren DX; Pan X; Li CX; Xu SY
Pain Ther; 2024 May; ():. PubMed ID: 38743247
[TBL] [Abstract][Full Text] [Related]
14. Determining the role of novel metabolic pathways in driving intracranial pressure reduction after weight loss.
Alimajstorovic Z; Mitchell JL; Yiangou A; Hancox T; Southam AD; Grech O; Ottridge R; Winder CL; Tahrani AA; Tan TM; Mollan SP; Dunn WB; Sinclair AJ
Brain Commun; 2023; 5(5):fcad272. PubMed ID: 37901040
[TBL] [Abstract][Full Text] [Related]
15. Proteomics profiling reveals mitochondrial damage in the thalamus in a mouse model of chronic migraine.
Xie W; Li R; Tang W; Ma Z; Miao S; Li C; Yang C; Li B; Wang T; Gong Z; Zhou Y; Yu S
J Headache Pain; 2023 Sep; 24(1):122. PubMed ID: 37667199
[TBL] [Abstract][Full Text] [Related]
16. Glia Signaling and Brain Microenvironment in Migraine.
Amani H; Soltani Khaboushan A; Terwindt GM; Tafakhori A
Mol Neurobiol; 2023 Jul; 60(7):3911-3934. PubMed ID: 36995514
[TBL] [Abstract][Full Text] [Related]
17. Co-morbid Polycystic Ovarian Syndrome with Idiopathic Intracranial Hypertension.
Thaller M; Adderley NJ; Subramanian A; Mollan SP; Sinclair AJ
Neuroophthalmology; 2023; 47(1):49-52. PubMed ID: 36798860
[TBL] [Abstract][Full Text] [Related]
18. Alterations in metabolic flux in migraine and the translational relevance.
Grech O; Sassani M; Terwindt G; Lavery GG; Mollan SP; Sinclair AJ
J Headache Pain; 2022 Sep; 23(1):127. PubMed ID: 36175833
[TBL] [Abstract][Full Text] [Related]
19. Cortical spreading depression and calcitonin gene-related peptide: a brief review of current progress.
Wang M
Neuropeptides; 2013 Dec; 47(6):463-6. PubMed ID: 24220568
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
